Sharekhan

Vineet Laboratories Ltd

Thu 2/04/2026,15:53:35 | NSE : VINEETLAB

₹ 29.510.04 (0.14%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 29.52

Previous Close

₹ 29.47

Volume

34369

Mkt Cap ( Rs. Cr)

₹56.68

High

₹ 30.21

Low

₹ 29.32

52 Week High

₹ 41.16

52 Week Low

₹ 27.96

Book Value Per Share

₹ 13.05

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Vineet Laboratories Ltd

Your Vote -

Buy

33.33%

Hold

0.00%

Sell

66.67%

33.33%

3 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

29.51

250

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

250

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Vineet Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vineet Laboratories - Trading Window

    30 Mar 2026, 4:54PM Vineet Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulatio
  • Vineet Laboratories - Copy of Newspaper Publication

    16 Feb 2026, 12:44PM We enclose herewith the copies of Un-audited standalone financial results of the company for the Third quarter and Nine months ended on December 31, 2
  • Vineet Laboratories - Outcome of Board Meeting

    14 Feb 2026, 4:24PM Outcome of Board Meeting held on Saturday, February 14, 2026 as required underRegulation 30 of Securities and Exchange Board of India (Listing Obligat
  • Vineet Laboratories - Outcome of Board Meeting

    14 Feb 2026, 4:15PM The Board of Directors of the company in its meeting held today i.e., Saturday, February 14, 2026 has:1. considered and approved the unaudited standal
  • Vineet Laboratories posts Q3 net profit of Rs 0.85 cr

    14 Feb 2026, 4:10PM The company reported standalone net profit during the quarter stood at Rs 0.85 crore compared to net loss of Rs 5.71 crore in the previous year quarte
  • Vineet Laboratories - Unaudited Standalone Financial Results Along With The Limited Review Report For The Period Ended On Dec

    14 Feb 2026, 4:07PM The Board of Directors in its meeting held today i.e on February 14, 2026 has considered and approved the Unaudited Standalone Financial Results along
  • Vineet Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, February 14, 2026 As Required Unde

    14 Feb 2026, 3:51PM The Board of Directors of the company in its meeting held today i.e., Saturday, February 14, 2026 has: \r\n considered and approved the unaudited sta
  • Vineet Laboratories - Board Meeting Intimation for Considering And Approving The Unaudited Standalone Financial Results Of Th

    10 Feb 2026, 1:33PM Vineet Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider
  • Vineet Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    7 Feb 2026, 5:24PM We are hereby submitting the Voting results of Extra-Ordinary General Meeting of Vineet Laboratories Limited held on Saturday, February 07, 2026.
  • Vineet Laboratories - Shareholders meeting

    7 Feb 2026, 5:18PM We are hereby submitting the voting results of the Extra-Ordinary General Meeting of Vineet Laboratories Limited held on Saturday, February 07, 2026.
  • Vineet Laboratories - Shareholders meeting

    7 Feb 2026, 5:09PM Vineet Laboratories Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on February 07, 2026 along with a c
  • Vineet Laboratories - Shareholder Meeting / Postal Ballot-Outcome of EGM

    7 Feb 2026, 4:56PM We are hereby submitting the proceedings of EGM of Vineet Laboratories Limited held on Saturday, February 07, 2026 through Video Conferencing (VC) / O
  • Vineet Laboratories - General Updates

    4 Feb 2026, 6:46PM We are hereby submitting the trading approvals received from BSE and NSE vide their letters dated February 04, 2026 for the Equity shares allotted und
  • Vineet Laboratories - Announcement Under Regulation 30 (LODR) - Trading Approval Received From BSE Limited And National Stock

    4 Feb 2026, 6:41PM We are hereby submitting the trading approvals received from BSE and NSE vide their letters dated February 04, 2026 for the Equity shares allotted und
  • Vineet Laboratories - Copy of Newspaper Publication

    4 Feb 2026, 4:14PM We are submitting copies of advertisements published by the Company today i.e. February 02, 2026, in respect of matters relating to Basis of Allotment
  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    2 Feb 2026, 6:04PM We would like to inform that the Rights Issue Committee of the Board of Directors of Vineet Laboratories Limited (\the Company\) has today i.e. Februa
  • Vineet Laboratories - Committee Meeting Updates

    2 Feb 2026, 5:57PM We would like to inform that the Rights Issue Committee of the Board of Directors of Vineet Laboratories Limited ( the Company ) has today i.e. Februa
  • Vineet Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    16 Jan 2026, 2:20PM As of December 2025, 12.46% is owned by Indian Promoters and 87.54% by Public. <p align=justify> Top five Promoters holding highest number of shares o
  • Vineet Laboratories - Copy of Newspaper Publication

    14 Jan 2026, 11:44AM We are hereby submitting the copies of the Addendum to the Letter of Offer dated December 17, 2025 published today in the following newspapers: 1. Fin
  • Vineet Laboratories - Copy of Newspaper Publication

    13 Jan 2026, 2:52PM We are hereby submitting the Newspaper publication made in Financial Express and Nava Telangana regarding the notice of Extra-Ordinary General Meeting
  • Vineet Laboratories - Committee Meeting Updates

    13 Jan 2026, 1:18PM The Rights Issue Committee of the Board of Directors in its meeting held on January 13, 2026, has decided to extend the ""Last date for On Market Renu
  • Vineet Laboratories - Announcement under Regulation 30 (LODR)-Meeting Updates

    13 Jan 2026, 1:12PM The Rights Issue Committee of the Board of Directors in its meeting held on January 13, 2026, has decided to extend the \Last date for On Market Renun
  • Vineet Laboratories - Shareholders meeting

    12 Jan 2026, 3:50PM The Extra-Ordinary General Meeting of the Company is being conducted on Saturday, February 07, 2026 at 11.00 A.M. We are hereby submitting the notice
  • Vineet Laboratories - Intimation Of Extra-Ordinary General Meeting Of The Company And Cut-Off Date

    12 Jan 2026, 3:42PM The Extra-Ordinary General Meeting of the Company is being conducted on Saturday, February 07, 2026 at 11.00 A.M. We are hereby submitting the notice
  • Vineet Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jan 2026, 6:35PM We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of th
  • Vineet Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jan 2026, 3:30PM We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with Regulation 74(5) of th
  • Vineet Laboratories - Outcome of Board Meeting

    7 Jan 2026, 2:57PM Outcome Of Board Meeting Held On Wednesday, January 07, 2026 As Required Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Ob
  • Vineet Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, January 07, 2026 As Required Unde

    7 Jan 2026, 2:51PM The Board of Directors of the company in its meeting held today i.e., on Wednesday, January 07, 2026 has approved:\r\n1. Notice of Extra - Ordinary Ge

Key fundamentals

Evaluate the intrinsic value of Vineet Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 54.6947 79.0239 64.7723 59.7318 39.0878
Liabilities 54.6947 79.0239 64.7723 59.7318 39.0878
Equity 9.219 9.219 9.219 9.219 9.219
Gross Profit -16.2831 7.2002 7.6597 13.2445 8.1456
Net Profit -20.191 1.0271 1.2525 6.6386 1.7802
Cash From Operating Activities 11.4909 -11.4272 -9.6162 0 -8.7123
NPM(%) -26.92 0.68 0.58 3.47 0.73
Revenue 74.995 150.5913 212.2933 191.1723 243.4789
Expenses 91.2781 143.3911 204.6336 177.9278 235.3333
ROE(%) -80.57 4.09 4.99 26.49 7.1

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
19 Sep 2022 1 10 0 58.75

Peers

Other companies within the same industry or sector that are comparable to Vineet Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 654.60 6.23 38.87 16.76 301.39 0.76
Lotus Eye Hospital and Institute Ltd 102.51 0.66 330.68 61.08 3.55 0.00
Vaishali Pharma Ltd 5.98 2.22 0.00 383.17 3.13 0.00
Astec Lifesciences Ltd 543.00 -2.66 0.00 57.60 -604.75 0.00

Company Info

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P. Vineet Laboratories Limited is also been certified as an ISO 14001: 2015 Company by the internationally recognised Quality Management Certification Body, in pursuance of its focus towards Environmental Management System.

Vineet Laboratories Limited ("Resulting Company") is a public limited company incorporated under the provisions of the Companies Act, 2013, on 10th day of November, 2016. The Corporate Identity Number of Resulting Company is U24304TG2016PLC112888. The objects of the Resulting Company enable it to carry on the business of manufacturing of bulk drugs intermediates and API Intermediates. The PAN of the Company is AAFCV6694P. Vineet Laboratories Limited is also been certified as an ISO 14001: 2015 Company by the internationally recognised Quality Management Certification Body, in pursuance of its focus towards Environmental Management System.

Read More

Parent Organisation

Vineet Laboratories Ltd.

Founded

10/11/2016

Managing Director

Mr.Gaddam Venkata Ramana

NSE Symbol

VINEETLABEQ

FAQ

The current price of Vineet Laboratories Ltd is ₹ 29.51.

The 52-week high for Vineet Laboratories Ltd is ₹ 30.21 and the 52-week low is ₹ 29.32.

The market capitalization of Vineet Laboratories Ltd is currently ₹ 56.68. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vineet Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vineet Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vineet Laboratories Ltd shares.

The CEO of Vineet Laboratories Ltd is Mr.Gaddam Venkata Ramana, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT